NO980721L - Vaksiner - Google Patents

Vaksiner

Info

Publication number
NO980721L
NO980721L NO980721A NO980721A NO980721L NO 980721 L NO980721 L NO 980721L NO 980721 A NO980721 A NO 980721A NO 980721 A NO980721 A NO 980721A NO 980721 L NO980721 L NO 980721L
Authority
NO
Norway
Prior art keywords
vaccinations
immunizing
individual
methods
addition
Prior art date
Application number
NO980721A
Other languages
English (en)
Other versions
NO980721D0 (no
Inventor
Robert Llewellyn Clancy
Original Assignee
Auspharm Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Auspharm Int Ltd filed Critical Auspharm Int Ltd
Publication of NO980721D0 publication Critical patent/NO980721D0/no
Publication of NO980721L publication Critical patent/NO980721L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Vaksiner anvendbare for å tilveiebringe beskyttelse mot infeksjoner i de nedre luftveier er tilveiebragt i tillegg til fremgangsmåter for immunisering av et individ.
NO980721A 1995-08-23 1998-02-20 Vaksiner NO980721L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9517269.8A GB9517269D0 (en) 1995-08-23 1995-08-23 Vaccines
PCT/GB1996/002048 WO1997007818A1 (en) 1995-08-23 1996-08-22 Vaccines

Publications (2)

Publication Number Publication Date
NO980721D0 NO980721D0 (no) 1998-02-20
NO980721L true NO980721L (no) 1998-04-22

Family

ID=10779652

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980721A NO980721L (no) 1995-08-23 1998-02-20 Vaksiner

Country Status (11)

Country Link
EP (1) EP0854728A1 (no)
JP (1) JPH11513028A (no)
KR (1) KR19990044013A (no)
CN (1) CN1198674A (no)
AU (1) AU726542B2 (no)
GB (1) GB9517269D0 (no)
MX (1) MXPA98001429A (no)
NO (1) NO980721L (no)
NZ (1) NZ316110A (no)
WO (1) WO1997007818A1 (no)
ZA (1) ZA967198B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2164148C1 (ru) * 2000-08-09 2001-03-20 Петров Рэм Викторович Вакцина против вируса гриппа и способ ее получения

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0225329B1 (en) * 1985-03-27 1992-08-12 Rhone-Poulenc Australia Pty. Limited Non-adjuvenated vaccine
US5643577A (en) * 1990-04-24 1997-07-01 The University Of Newcastle Research Associates Limited Oral vaccine comprising antigen surface-associated with red blood cells
AUPM572294A0 (en) * 1994-05-18 1994-06-09 Vaccine Technologies Pty. Ltd. Delivery vehicle for bioactive molecule

Also Published As

Publication number Publication date
MXPA98001429A (es) 2003-09-11
EP0854728A1 (en) 1998-07-29
GB9517269D0 (en) 1995-10-25
CN1198674A (zh) 1998-11-11
NZ316110A (en) 1999-11-29
WO1997007818A1 (en) 1997-03-06
AU726542B2 (en) 2000-11-09
NO980721D0 (no) 1998-02-20
JPH11513028A (ja) 1999-11-09
AU6826896A (en) 1997-03-19
ZA967198B (en) 1998-02-23
KR19990044013A (ko) 1999-06-25

Similar Documents

Publication Publication Date Title
NO950881L (no) Nöytraliserende monoklonale menneske-antistoffer mot respiratorisk syncytialt virus
DE69637481D1 (de) Aus immunisierten Xenomäusen stammende menschliche Antikörper gegen IL-8
FI972945L (fi) Antigeenien antamiseen soveltuvia koostumuksia
ATE188508T1 (de) Impfstoffe gegen diphtherietoxin
NL194940B (nl) Virusstam en vaccin ter voorkoming van varkensreproductie- en -respiratiesyndroom.
DK0671948T3 (da) Vaccinepræparat indeholdende adjuvanser
FR2629717B1 (fr) Preparation de vaccin
FI944052A0 (fi) Oraalinen rokote
DK0765333T3 (da) Quillajasaponinadjuvans og vaccineformulering, der indeholder denne
DK0859957T3 (da) Patientspecifikke immunadsorbenser til ekstraporal apherese og fremgangsmåde til deres fremstilling
WO1994010317A3 (en) Conjugate vaccine against group b streptococcus
ATE212540T1 (de) Antitumorvakzine
NZ312502A (en) Clostridium difficile toxins as mucosal adjuvants
DE69629457D1 (de) Impfstoff in gelform
NL300112I1 (nl) Vaccin tegen dermatomycosis.
NO980721L (no) Vaksiner
EP1123711A4 (en) VACCINE PREPARATIONS CONTAINING AN ABRASIVE TOXIN
DE69331459D1 (de) Parenterale immunisierung gegen rotavirus
NO934106L (no) Liposome polysakkarid-vaksiner
ATE187339T1 (de) Auf helicobacter pylori katalase basierende immunisierende zusammensetzung
AU2548597A (en) Antibodies against avirulence/pathogenicity proteins of plant pathogens
PL326839A1 (en) Compositions based on cyclic polysiloxanes for fighting against pests
WO2002004497A3 (en) Multiple antigenic peptides immunogenic against streptococcus pneumoniae
DE69123252D1 (de) Kreuzreaktive immunisierung gegen influenza
Owen The border Southern Hungary

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application